ENIGMA-TRS 1 is an international, one-year, double-blind, placebo-controlled Phase III study in at least 600 patients; enrollment to start imminently; 12-week study results expected in Q4 2026 ...

STAMFORD, Conn., April 11, 2006 (PRIMEZONE) -- Enigma Software Group, Inc. (OTCBB:ENGM), ("Enigma" and/or the "Company"), which yesterday filed its annual report to the Securities and Exchange ...

CLEARWATER, Florida, March 3, 2017 /PRNewswire/ -- Enigma Software Group USA, LLC ("ESG") announced that it reached a settlement in the lawsuit it filed last year against Bleeping Computer LLC. The ...

Many, many years ago, when PCs were a lot newer to the world and I was slightly younger (I claim reverse dog years), I remember my father came up with the idea of software to manage equipment ...

What just happened? Enigma Software Group has won a crucial case in the U.S. Court of Appeals for the Ninth Circuit, allowing it to proceed with its lawsuit against Malwarebytes for flagging its ...

Florida-based Enigma Software Grp. USA LLC markets the SpyHunter anti-malware computer program. Santa Clara, California-based competitor Malwarebytes' own Anti-Malware (MBAM) detects and removes ...

Ars Technica has been separating the signal from the noise for over 25 years. With our unique combination of technical savvy and wide-ranging interest in the technological arts and sciences, Ars is ...